ENDRA Life Sciences Inc.
NDRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $794 | $1,809 | $2,065 | $3,229 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $255 | $44 | $115 | $204 |
| Total Curr. Assets | $1,049 | $1,853 | $2,180 | $3,434 |
| Property Plant & Equip (Net) | $544 | $583 | $619 | $647 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $371 | $371 | $371 | $371 |
| Total NC Assets | $915 | $955 | $990 | $1,019 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,964 | $2,808 | $3,171 | $4,452 |
| Liabilities | – | – | – | – |
| Payables | $252 | $282 | $224 | $270 |
| Short-Term Debt | $129 | $128 | $126 | $97 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $419 | $166 | $216 | $239 |
| Total Curr. Liab. | $800 | $577 | $566 | $605 |
| LT Debt | $397 | $429 | $461 | $487 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $596 | $329 | $391 | $799 |
| Total NC Liab. | $992 | $758 | $852 | $1,287 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $397 | $557 | $587 | $584 |
| Total Liabilities | $1,793 | $1,335 | $1,418 | $1,892 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$107,296 | -$105,700 | -$104,474 | -$103,438 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $107,468 | $107,173 | $106,227 | $105,998 |
| Total Equity | $171 | $1,473 | $1,753 | $2,560 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,964 | $2,808 | $3,171 | $4,452 |
| Net Debt | -$269 | -$1,251 | -$1,478 | -$2,645 |